Medine.co.uk

Panadol Actifast

Document: label-leaflet MAH BRAND_PL 44673-0082 change

OUTSIDE

TAKE SPECIAL CARE

tamol-containing products.

■HTWirr

glass of water (100 ml), every 4 hours a than every 4 hours.

Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage.

Adults and children aged 12 ye Swallow 2 tablets with half a

Do not take more frequently than every 4 hours. Do not take more than 8 tablets in 24 hours.

Do not take more than the recommended dose. Do not give to children under 12 years.

I Do not exceed the stated dose.

If your symptoms persist consult your doctor.

Keep out of the reach and sight of children.

GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.

GlaxoSmithKline PL 44673/0082 62000000005980 D328125/09


Please read right through the information on the outside and inside of this pack before you start using this medidne.

If you have any questions, or if there is anything you do not understand, ask your pharmacist WHAT ARE THEY FOR?

Panadol ActiFast has a unique formulation which gets to the source of pain fast. It acts faster than standard paracetamol tablets you can swallow to aive fast pain relief of headaches, including migraine and tension headaches, toothache, backache, rheumatic and muscle pain and period pain. It also relieves sore throat and the fever, aches and pains of colds and flu.


• if you have liver or kidney disease, including alcoholic liver disease

> if you are on a controlled sodium diet (see Section 2 inside for more information


Each tablet contains Paracetamol 500 mg. Also contains potassium sorbate (E 202). Do not store above 25°C.



INSIDE


PANADOL

nnaacnas


ACT


FAST


Panadol ActiFast has a unique formulation which gets to the source of pain fast.

The active Ingredient is paracetamol which is a painkiller and also reduces your temperature when you have a fever.


ui


Do not take Panadol ActiFast:

• If you have ever had an allergic reaction to

paracetamol or to any of the other Ingredients (listed In Section 4).

Askyour doctor before you take this medicine:

• If you are on a controlled sodium diet. Each 2 tablet dose contains 346 mg of sodium.

If you are taking other medicines

Talk to your doctor or pharmacist before taking

_ these tablets If you are taking any prescribed

medicines; particularly metoclopramlde or dom perl done (for nausea [feeling sick] or vomiting [being sick]) or colestyramtne (to lower blood cholesterol), if you take blood thinning drugs (anticoagulants e g. warfarin) and you need to take a pain reliever on a dally basis, talk to your doctor because of the risk of bleeding. But you can still take occasional doses of Panadol ActiFast at the same time as anticoagulants.

Pregnancy and breast feeding Talk to your doctor before taking Panadol ActiFast If you are pregnant. You can take this product whilst breast feeding.


Like all medicines, Panadol ActiFast can have side effects but not everybody gets them. A small number of people have had side effects. Stop taking the medicine and tell


your doctor immediately If you experience:

•    Allergic reactions which may be severe such as skin rash and Itching sometimes with swelling of the mouth or face or shortness of breath

•    Sldn rash or peeling, or mouth ulcers

•    Breathing problems. These are more likely If you have experienced them before when taking other painkillers such as Ibuprofen and aspirin

•    Unexplained bruising or bleeding

•    Nausea, sudden weight loss, loss of appetite and yellowing of the eyes and skin.

If you do get any side effects, even those not mentioned In this Information, tell your doctor or pharmacist.

If your symptoms continue or your headache becomes persistent, see your doctor.

Active Ingredient: Each tablet contains Paracetamol 500 mg. Other Ingredients: Sodium bicarbonate, starch pregelatinised, povidone, maize starch, potassium sorbate (E 202), microcrystal line cellulose, magnesium stearate, camauba wax, dtanlum dioxide (E 171), polydextrose, hypromellose, glycerol triacetate and polyethylene glycol.

Packs of Panadol ActiFast contain 8 or 14 tablets.

The marketing authorisation holder Is GlaxoSmithKline Consumer Flealthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. and all enquiries should be sent to this address.

The manufacturer Is GlaxoSmithKline Dungarvan Ltd.,

Co. Waterford, Ireland.

This Information was last revised In March 2016.

Panadol, ActiFast and the Triangle device are registered trademarks owned by or licensed to the GSK group of companies.


ansGQBC

TABLETS

Only Braille text, will not be printed

The Market is fully responsible for the approval and certification of the Braille translation and content


GlaxoSmithKline


FOR CONTENT ONLY

For colour please match to existing Material No: 40U572F

62000000005980    D328125/09


^GlaxoSmithKline


Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1405

Varnish Type

UV

Generic Specification Reference No.

OTC.UC.SPEC.023


TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt


GlaxoSmithKline

Item Number:

Manufacturing Site:

Artwork Information Panel

62000000005980

GSK-IRL-Dungarvan (OTC)-IEDUN


Smallest text size: 5.0pt


Microtext: No


ee

a

EE

EE

a

.

EE

E

EE

ED

.

EE

Ei

EE

EE

tE

.

:

.

ee

.

EE



INSIDE


E™™E]

P A N A D 0 L

nnaacnas

ACT I FAST

ansGQBC



TABLETS

Only Braille text, will not be printed

The Market is fully responsible for the approval and certification of the Braille translation and content


GlaxoSmithKline


FOR CONTENT ONLY

For colour please match to existing Material No: 40U572F

Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1405

Varnish Type

UV

Generic Specification Reference No.

OTC.UC.SPEC.023

TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt

GlaxoSmithKline

Item Number:

Manufacturing Site:

c

o

'a

Smallest text size: 5.0pt

Artwork Information Panel

62000000005980

GSK-IRL-Dungarvan (OTC)-IEDUN

>

5

Microtext: No



INSIDE


PANADOL

nnaacnas


ACT


FAST


Panadol ActlFast has a unique formulation which gets to the source of pain fast.

The active Ingredient is paracetamol which is a painkiller and also reduces your temperature when you have a fever.


ui


Do not take Panadol ActlFast:

• If you have ever had an allergic reaction to

paracetamol or to any of the other Ingredients (listed In Section 4).

Askyour doctor before you take this medicine:

• if you are on a controlled sodium diet. Each 2 tablet dose contains 346 mg of sodium.

If you are taking other medicines

Talk to your doctor or pharmacist before taking

_ these tablets If you are taking any prescribed

medicines; particularly metoclopramlde or dom perl done (for nausea [feeling sick] or vomiting [being sick]) or colestyramlne (to lower blood cholesterol), if you take blood thinning drugs (anticoagulants e g. warfarin) and you need to take a pain reliever on a dally basis, talk to your doctor because of the risk of bleeding. But you can still take occasional doses of Panadol ActlFast at the same time as anticoagulants.

Pregnancy and breast feeding Talk to your doctor before taking Panadol ActlFast If you are pregnant. You can take this product whilst breast feeding.


Like all medicines, Panadol ActlFast can have side effects but not everybody gets them. A small number of people have had side effects. Stop taking the medicine and tell


your doctor immediately If you experience:

•    Allergic reactions which may be severe such as skin rash and Itching sometimes with swelling of the mouth or face or shortness of breath

•    Sldn rash or peeling, or mouth ulcers

•    Breathing problems. These are more likely If you have experienced them before when taking other painkillers such as Ibuprofen and aspirin

•    Unexplained bruising or bleeding

•    Nausea, sudden weight loss, loss of appetite and yellowing of the eyes and skin.

If you do get any side effects, even those not mentioned In this Information, tell your doctor or pharmacist.

If your symptoms continue or your headache becomes persistent, see your doctor.

Active Ingredient: Each tablet contains Paracetamol 500 mg. Other Ingredients: Sodium bicarbonate, starch pregelatinised, povidone, maize starch, potassium sorbate (E 202), microcrystal line cellulose, magnesium stearate, camauba wax, dtanlum dioxide (E 171), polydextrose, hypromellose, glycerol triacetate and polyethylene glycol.

Packs of Panadol ActlFast contain 8 or 14 tablets.

The marketing authorisation holder Is GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. and all enquiries should be sent to this address.

The manufacturer Is GlaxoSmithKline Dungarvan Ltd.,

Co. Waterford, Ireland.

This Information was last revised In March 2016.

Panadol, ActlFast and the Triangle device are registered trademarks owned by or licensed to the GSK group of companies.


ansGQBC

TABLETS

Only Braille text, will not be printed

The Market is fully responsible for the approval and certification of the Braille translation and content


GlaxoSmithKline


FOR CONTENT ONLY

For colour please match to existing Material No: 40U572F

62000000005980    D328125/09


^GlaxoSmithKline


Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1405

Varnish Type

UV

Generic Specification Reference No.

OTC.UC.SPEC.023


TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt


GlaxoSmithKline

Item Number:

Manufacturing Site:

Artwork Information Panel

62000000005980

GSK-IRL-Dungarvan (OTC)-IEDUN


Smallest text size: 5.0pt


Microtext: No


TAKE SPECIAL CARE

tamol-containing products.

■HTWirr

glass of water (100 ml), every 4 hours a than every 4 hours.

Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage.

Adults and children aged 12 ye Swallow 2 tablets with half a

Do not take more frequently than every 4 hours. Do not take more than 8 tablets in 24 hours.

Do not take more than the recommended dose. Do not give to children under 12 years.

I Do not exceed the stated dose.

If your symptoms persist consult your doctor.

Keep out of the reach and sight of children.

GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.

GlaxoSmithKline PL 44673/0082 62000000005980 D328125/09


Please read right through the information on the outside and inside of this pack before you start using this medidne.

If you have any questions, or if there is anything you do not understand, ask your pharmacist WHAT ARE THEY FOR?

Panadol ActiFast has a unique formulation which gets to the source of pain fast. It acts faster than standard paracetamol tablets you can swallow to aive fast pain relief of headaches, including migraine and tension headaches, toothache, backache, rheumatic and muscle pain and period pain. It also relieves sore throat and the fever, aches and pains of colds and flu.


• if you have liver or kidney disease, including alcoholic liver disease

> if you are on a controlled sodium diet (see Section 2 inside for more information


Each tablet contains Paracetamol 500 mg. Also contains potassium sorbate (E 202). Do not store above 25°C.



INSIDE


PANADOL

nnaacnas


ACT


FAST


Panadol ActiFast has a unique formulation which gets to the source of pain fast.

The active Ingredient is paracetamol which is a painkiller and also reduces your temperature when you have a fever.


ui


Do not take Panadol ActiFast:

• If you have ever had an allergic reaction to

paracetamol or to any of the other Ingredients (listed In Section 4).

Askyour doctor before you take this medicine:

• If you are on a controlled sodium diet. Each 2 tablet dose contains 346 mg of sodium.

If you are taking other medicines

Talk to your doctor or pharmacist before taking

_ these tablets If you are taking any prescribed

medicines; particularly metoclopramlde or dom perl done (for nausea [feeling sick] or vomiting [being sick]) or colestyramtne (to lower blood cholesterol), if you take blood thinning drugs (anticoagulants e g. warfarin) and you need to take a pain reliever on a dally basis, talk to your doctor because of the risk of bleeding. But you can still take occasional doses of Panadol ActiFast at the same time as anticoagulants.

Pregnancy and breast feeding Talk to your doctor before taking Panadol ActiFast If you are pregnant. You can take this product whilst breast feeding.


Like all medicines, Panadol ActiFast can have side effects but not everybody gets them. A small number of people have had side effects. Stop taking the medicine and tell


your doctor immediately If you experience:

•    Allergic reactions which may be severe such as skin rash and Itching sometimes with swelling of the mouth or face or shortness of breath

•    Sldn rash or peeling, or mouth ulcers

•    Breathing problems. These are more likely If you have experienced them before when taking other painkillers such as Ibuprofen and aspirin

•    Unexplained bruising or bleeding

•    Nausea, sudden weight loss, loss of appetite and yellowing of the eyes and skin.

If you do get any side effects, even those not mentioned In this Information, tell your doctor or pharmacist.

If your symptoms continue or your headache becomes persistent, see your doctor.

Active Ingredient: Each tablet contains Paracetamol 500 mg. Other Ingredients: Sodium bicarbonate, starch pregelatinised, povidone, maize starch, potassium sorbate (E 202), microcrystal line cellulose, magnesium stearate, camauba wax, dtanlum dioxide (E 171), polydextrose, hypromellose, glycerol triacetate and polyethylene glycol.

Packs of Panadol ActiFast contain 8 or 14 tablets.

The marketing authorisation holder Is GlaxoSmithKline Consumer Flealthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. and all enquiries should be sent to this address.

The manufacturer Is GlaxoSmithKline Dungarvan Ltd.,

Co. Waterford, Ireland.

This Information was last revised In March 2016.

Panadol, ActiFast and the Triangle device are registered trademarks owned by or licensed to the GSK group of companies.


ansGQBC

TABLETS

Only Braille text, will not be printed

The Market is fully responsible for the approval and certification of the Braille translation and content


GlaxoSmithKline


FOR CONTENT ONLY

For colour please match to existing Material No: 40U572F

62000000005980    D328125/09


^GlaxoSmithKline


Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1405

Varnish Type

UV

Generic Specification Reference No.

OTC.UC.SPEC.023


TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt


GlaxoSmithKline

Item Number:

Manufacturing Site:

Artwork Information Panel

62000000005980

GSK-IRL-Dungarvan (OTC)-IEDUN


Smallest text size: 5.0pt


Microtext: No


ee

a

EE

EE

a

.

EE

E

EE

ED

.

EE

Ei

EE

EE

tE

.

:

.

ee

.

EE



INSIDE


E™™E]

P A N A D 0 L

nnaacnas

ACT I FAST

ansGQBC



TABLETS

Only Braille text, will not be printed

The Market is fully responsible for the approval and certification of the Braille translation and content


GlaxoSmithKline


FOR CONTENT ONLY

For colour please match to existing Material No: 40U572F

Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1405

Varnish Type

UV

Generic Specification Reference No.

OTC.UC.SPEC.023

TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt

GlaxoSmithKline

Item Number:

Manufacturing Site:

c

o

'a

Smallest text size: 5.0pt

Artwork Information Panel

62000000005980

GSK-IRL-Dungarvan (OTC)-IEDUN

>

5

Microtext: No


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251




ADVANCEMENT DIRECTION

->


IMPORTANT


GSK Market is responsible for this product, its design and content.

Ensure the artwork is thoroughly checked, all the text proof-read and approved.

RSC GSK is responsible for site technical requirements and pre-press suitability.


TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt Smallest text size: 6.0pt Microtext: N


Dungarvan Additional Information Panel


Reel Unwind Direction


3

Artwork copyright is the property of the GlaxoSmithKline Group of Companies

All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.


ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION

To Ensure Accurate PDF Viewing and Printing:

FOR SCREEN VIEWING: Use Adobe Acrobat 7 Professional or Adobe Acrobat Reader, Standard or Professional (higher than 7).

Overprint Preview must be activated for accurate on screen viewing.

FOR PRINTING: Use only Acrobat Professional version 7 or higher. "Apply Overprint Preview" or "Simulate Overprinting" must be activated in the print settings for printing accurate hard copies.


180 mm Measuring Bar

If a status identification banner DOES NOT appear on this document, THEN this document has NOT been printed from the Global Pack Management system.


GSK Market

is responsible to advise RSC in case changes required impact the followings:

Formulation Tablet embossing Storage conditions Shelf Life


Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1251

Varnish Type

N/A

Generic Specification Reference No.

OTC.FL.SPEC.005


This PDF has been verified using PitStop 12 PDF is PDF/X-4 compliant and GSK compliant for Foils workflow


Page 1 of 2


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251


Pharma code Ref. No. 1251




ADVANCEMENT DIRECTION

->


IMPORTANT


GSK Market is responsible for this product, its design and content.

Ensure the artwork is thoroughly checked, all the text proof-read and approved.

RSC GSK is responsible for site technical requirements and pre-press suitability.


TEXT SIZE CONTAINED IN THIS ARTWORK


Body text size: 6.0pt Smallest text size: 6.0pt Microtext: N


Dungarvan Additional Information Panel


Reel Unwind Direction


3

Artwork copyright is the property of the GlaxoSmithKline Group of Companies

All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.


ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION • ATTENTION

To Ensure Accurate PDF Viewing and Printing:

FOR SCREEN VIEWING: Use Adobe Acrobat 7 Professional or Adobe Acrobat Reader, Standard or Professional (higher than 7).

Overprint Preview must be activated for accurate on screen viewing.

FOR PRINTING: Use only Acrobat Professional version 7 or higher. "Apply Overprint Preview" or "Simulate Overprinting" must be activated in the print settings for printing accurate hard copies.


180 mm Measuring Bar

If a status identification banner DOES NOT appear on this document, THEN this document has NOT been printed from the Global Pack Management system.


GSK Market

is responsible to advise RSC in case changes required impact the followings:

Formulation Tablet embossing Storage conditions Shelf Life


FOR TECHNICAL AND ADVANCED CHECK


This PDF has been verified using PitStop 12 PDF is PDF/X-4 compliant and GSK compliant for Foils workflow


Dungarvan - Additional Artwork Information Panel

Pharmacode No.

1251

Varnish Type

N/A

Generic Specification Reference No.

OTC.FL.SPEC.005


Page 2 of 2